Metraipolis › archive › dc_96ce8cb86a20
Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis — Europe PMC PMID:37226748
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/37226748
- DOI
- 10.1017/jme.2023.53
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T20:43:57.774Z
- SHA-256 of the archived text
39f6ea1837c99ddff4cf05659d7a3486fdd54c7e9da6957fa9a7fba1f1ab95c3- Stable URL of this page
https://metraipolis.com/documento/dc_96ce8cb86a20
How to cite
Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis — Europe PMC PMID:37226748 — Europe PMC (en), https://europepmc.org/article/MED/37226748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96ce8cb86a20 (Metraipolis archive dc_96ce8cb86a20, sha256 39f6ea1837c99ddff4cf05659d7a3486fdd54c7e9da6957fa9a7fba1f1ab95c3)
BibTeX
@misc{dc96ce8cb86a20,
title = {Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis — Europe PMC PMID:37226748},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/37226748},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96ce8cb86a20; sha256 39f6ea1837c99ddff4cf05659d7a3486fdd54c7e9da6957fa9a7fba1f1ab95c3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37226748. Agents can read the archived copy with the MCP tool read_document.